BridgeBio Pharma (BBIO) P/E (2019 - 2026)
BridgeBio Pharma (BBIO) P/E from Sep 30, 2019 to Jul 21, 2026. The TTM BridgeBio Pharma (BBIO) P/E is -21.86. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of BridgeBio Pharma (BBIO)
| Year | P/E | Change |
|---|---|---|
| 2026 | -21.86 | +9.01% |
| 2025 | -20.05 | +109.83% |
| 2024 | -9.56 | -8.87% |
| 2023 | -10.49 | +361.43% |
| 2022 | -2.27 | -46.07% |
| 2021 | -4.21 | -75.50% |
| 2020 | -17.20 | -11.74% |
| 2019 | -19.49 | N/A |
Comparison BridgeBio Pharma (BBIO) P/E with competitors
BridgeBio Pharma (BBIO) P/E is -21.86.